FDA warns Asians of epilepsy med risks

Treatment with certain epilepsy drugs--such as Pfizer's Dilantin, Bertek Pharmaceuticals' Phenytek and Eisai's Cerebyx--may expose some Asian patients to serious skin reactions, the FDA warned Monday. Report

Suggested Articles

Intercept presented a data analysis that found treatment with Ocaliva led to "early and consistent improvements" in a range of noninvasive tests.

Intent-driven audiences are inspired to make health-improving changes after a positive online experience. Find out what they’re driven to do.

Days before Amarin faces a pivotal FDA vote on its Vascepa expansion, advisors are set to scrutinize the placebo used in its pivotal outcomes trial.